marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Viemed Healthcare Balance Sheet 2011-2024 | VMD
Annual Balance Sheet Viemed Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-22.6 M | -23.3 M | -3.98 M | -6.99 M | 81 K | 2.15 M | - | - | - | - | - | ||
Long Term Debt |
6 M | - | 4.31 M | 5.8 M | 7.63 M | - | - | - | - | - | - | - | - |
Long Term Debt Current |
678 K | 495 K | 1.48 M | 1.84 M | 1.75 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
8.88 M | 1.09 M | 5.33 M | 7.85 M | 13 M | 1.51 M | 798 K | 2.63 M | - | - | - | - | - |
Total Current Liabilities |
32.1 M | 18.9 M | 17.8 M | 23 M | 25.9 M | - | - | - | - | - | - | - | - |
Total Liabilities |
41 M | 19.9 M | 23.1 M | 30.9 M | 38.9 M | 18.5 M | 13.9 M | 11.8 M | - | - | - | - | - |
Deferred Revenue |
6.21 M | 4.62 M | 3.75 M | 3.41 M | 3.32 M | - | - | - | - | - | - | - | - |
Retained Earnings |
79.5 M | 69.8 M | 73.3 M | 65.6 M | 34.1 M | 29.6 M | 21 M | 12.8 M | - | - | - | - | - |
Total Assets |
155 M | 117 M | 118 M | 113 M | 82.6 M | 53.5 M | 37.7 M | 24.7 M | - | - | - | - | - |
Cash and Cash Equivalents |
12.8 M | 16.9 M | 28.4 M | 31 M | 13.4 M | 10.4 M | - | - | - | - | - | - | - |
Book Value |
114 M | 97.1 M | 94.8 M | 81.7 M | 43.7 M | 35 M | 23.7 M | 12.9 M | - | - | - | - | - |
Total Shareholders Equity |
114 M | 97.1 M | 94.8 M | 81.7 M | 43.7 M | 32.6 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Viemed Healthcare
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
3.65 M | 8.72 M | 5.91 M | 6 M | 8.1 M | 12.1 M | - | - | 4.16 M | - | 4.27 M | 4.31 M | 4.35 M | 4.85 M | 5.32 M | 5.8 M | 5.8 M | 5.8 M | 5.8 M | 7.63 M | 7.63 M | 7.63 M | 7.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
6.29 M | 11.3 M | 8.48 M | 8.88 M | 9.03 M | 13 M | 1.17 M | 1.09 M | 4.95 M | - | 5.23 M | 5.33 M | 5.91 M | 6.43 M | 7.72 M | 7.85 M | 7.85 M | 7.85 M | 7.85 M | 13 M | 13 M | 13 M | 13 M | 1.51 M | 1.51 M | 1.51 M | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
42.7 M | 42.8 M | 38.6 M | 41 M | 40.6 M | 44.6 M | 24.6 M | 19.9 M | 25.5 M | - | 23 M | 23.1 M | 26.1 M | 24.8 M | 29.6 M | 30.9 M | 30.9 M | 30.9 M | 30.9 M | 38.9 M | 38.9 M | 38.9 M | 38.9 M | 21.1 M | 18.5 M | 18.5 M | 15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
6.82 M | 6.72 M | 6.09 M | 6.21 M | 6.22 M | 5.96 M | 4.7 M | 4.62 M | 4.64 M | - | 3.89 M | 3.75 M | 3.8 M | 3.74 M | 3.42 M | 3.41 M | 3.41 M | 3.41 M | 3.41 M | 3.32 M | 3.32 M | 3.32 M | 3.32 M | 2.59 M | 2.48 M | 2.27 M | 2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
85.4 M | 81.6 M | 80.1 M | 79.5 M | 76 M | 73.2 M | 70.9 M | 69.8 M | 68.1 M | - | 73.1 M | 73.3 M | 69.2 M | 67.5 M | 65.9 M | 65.6 M | 65.6 M | 65.6 M | 65.6 M | 34.1 M | 34.1 M | 34.1 M | 34.1 M | 27.1 M | 29.6 M | 29.6 M | 21.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
170 M | 164 M | 155 M | 155 M | 149 M | 149 M | 125 M | 117 M | 119 M | - | 119 M | 118 M | 115 M | 111 M | 113 M | 113 M | 113 M | 113 M | 113 M | 82.6 M | 82.6 M | 82.6 M | 82.6 M | 53.7 M | 53.5 M | 53.5 M | 40.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
11.3 M | 8.81 M | 7.31 M | 12.8 M | 10.1 M | 10.2 M | 23.5 M | 16.9 M | 21.5 M | 21.9 M | 29.2 M | 28.4 M | 26.9 M | 31.2 M | 31.1 M | 31 M | 31 M | 31 M | 31 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 10.4 M | 10.4 M | 10.4 M | 4.63 M | 5.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
127 M | 121 M | 116 M | 114 M | 109 M | 105 M | 100 M | 97.1 M | 93.9 M | - | 96 M | 94.8 M | 89.4 M | 86.3 M | 83.4 M | 81.7 M | 81.7 M | 81.7 M | 81.7 M | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 32.6 M | 35 M | 35 M | 24.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
125 M | 119 M | 116 M | 114 M | 109 M | 105 M | 100 M | 97.1 M | 93.9 M | 93.2 M | 96 M | 94.8 M | 89.4 M | 86.3 M | 83.4 M | 81.7 M | 81.7 M | 81.7 M | 81.7 M | 43.7 M | 43.7 M | 43.7 M | 43.7 M | 32.6 M | 35 M | 35 M | 24.7 M | 22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency